The Use of Oxytocin as Adjunctive Therapy for the Treatment of Schizophrenia: a Randomized, Double Blind Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 24 Feb 2016 Biomarkers information updated
- 10 Aug 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2012-004504-35).
- 17 Oct 2012 New trial record